Incidence of Premature Discontinuation of Antiplatelet Therapy After Sirolimus-Eluting Stent Implantation

254 patients with sirolimus-eluting stents (SES) implantation, mean age 67, 80% male, in Japan.

Premature discontinuation of antiplatelet therapy (aspirin plus ticlopidine, clopidogrel, or cilostazol)

Incidence of discontinuation of antiplatelet therapy and subsequent adverse cardiac events (death, myocardial infarction, target lesion revascularization, stent thrombosis)hard clinical